Neurosteroids are excitatory in supraoptic neurons but inhibitory in the peripheral nervous system: it is all about oxytocin and progesterone receptors.
Neuroactive steroids synthesized from the brain or peripheral sources are called neurosteroids. Beside their common nuclear effects, they are considered to be potent neuromodulators, acting rapidly mainly in a non-genomic manner, either through allosteric regulation of ionic channels, or through membrane-bound steroid receptors. In contrast to the situation in the adult, the neurotransmitter GABA is excitatory during development and plays a trophic role, in particular inducing calcium signals necessary for the regulation of excitability and neuronal maturation. We demonstrated that the primary metabolite of progesterone (Proges), allopregnanolone (Allo), evoked a robust Ca(2+) influx in foetal hypothalamic neurons and in postnatal supraoptic nucleus (SON) neurons. In the latter, this led to oxytocin and arginine vasopressin release. Interestingly, these responses were GABA(A) and oxytocin-receptor-dependent. Allo is a well-known positive allosteric modulator of GABA(A) receptors. It is noteworthy that two other steroids, Proges and 17-beta-estradiol, displayed the same effect on Ca(2+) and oxytocin release but to a lesser extent. Importantly, no effect was observed in adult neurons from the SON, or in neurohypophysial axon terminals, regardless of the stage. The molecular mechanisms of the neurosteroid actions are multifaceted and depend on the type of cells, and are thus extremely interesting and challenging. In the peripheral nervous system, Allo and Proges surprisingly inhibited the GABA-induced Ca(2+) increases in embryonic dorsal root ganglion neurons. We propose that this rapid, reversible and dose-dependent phenomenon (at very low concentrations) was mediated by membrane Proges receptors, since transcripts for a newly discovered receptor protein, 25-Dx, were detected in our model. Recently, novel families of membrane steroid receptors, activating intracellular-signalling pathways such as MAP kinases, have been identified and described. This opens new perspectives to understand the intracellular machinery involved in the interaction between neuropeptides and neurosteroids, two major regulators of hypothalamo-neurohypophysial system development.
Viero
Cedric
C
Institute for Molecular Cell Biology, Medical Faculty, Saarland University, Homburg/Saar, Germany.
Dayanithi
Govindan
G
D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002462:Cell Membrane / Q000502:physiology; D005727:Ganglia, Spinal / Q000502:physiology; D006728:Hormones / Q000502:physiology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D007031:Hypothalamus / Q000196:embryology / Q000502:physiology; D007473:Ion Channels / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D009479:Neuropeptides / Q000502:physiology; D010121:Oxytocin / Q000502:physiology*; D017933:Peripheral Nervous System / Q000502:physiology*; D011374:Progesterone / Q000378:metabolism; D011372:Progestins / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D011980:Receptors, Progesterone / Q000502:physiology*; D011987:Receptors, Steroid / Q000502:physiology; D013495:Supraoptic Nucleus / Q000502:physiology*
D006728:Hormones; D007473:Ion Channels; D009479:Neuropeptides; D011372:Progestins; D011956:Receptors, Cell Surface; D011980:Receptors, Progesterone; D011987:Receptors, Steroid; D001127:Arginine Vasopressin; D011374:Progesterone; D010121:Oxytocin; D002118:Calcium